An autosomal dominant disorder caused by pathogenic variants in the VHL gene, leading to an increased risk of various benign and malignant tumors, including hemangioblastomas, retinal hemangiomas, endolymphatic sac tumors, renal cell carcinoma, and pheochromocytomas. The disease is von Hippel-Lindau disease (MONDO_0008667, a Monarch Disease Ontology term). Also known as: Hippel Lindau syndrome, Lindau disease, VHL, VHL-related von Hippel-Lindau disease, Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome (VHL), cerebroretinal angiomatosis, familial cerebelloretinal angiomatosis.